GO enrichment analysis of DEPs.

GO enrichment analysis of DEPs.

<p><b>(A)</b> GO analysis of upregulated DEPs. <b>(B)</b> GO analysis of downregulated DEPs.</p>

Tallennettuna:

Bibliografiset tiedot
Päätekijä:	Jing Liu (38537) (author)
Muut tekijät:	Junshuang Wang (22683435) (author), Shuang Lv (660117) (author), Hengjiao Wang (21539904) (author), Defu Yang (735577) (author), Ying Zhang (40767) (author), Ying Li (38224) (author), Huiling Qu (6104225) (author), Ying Xu (9172) (author), Ying Yan (47692) (author)
Julkaistu:	2025
Aiheet:	Biophysics Biochemistry Medicine Cell Biology Genetics Molecular Biology Neuroscience Pharmacology Evolutionary Biology Cancer Mental Health Infectious Diseases Biological Sciences not elsewhere classified Chemical Sciences not elsewhere classified tandem mass tagging resolution mass spectrometry 30 gy ). induced brain injury ribi &# 8217 ppi network analysis key hub protein kegg analysis highlighted identifying key proteins xlink "> radiation identify potential biomarkers xlink "> potential biomarkers potential role brain tumors brain tissues brain tissue brain irradiation tight junctions therapeutic targets targeted therapies study aims ribi pathophysiology rat model protein interaction ppar signaling pathways related pathways involved pathway analyses neurological impairments neurocognitive deficits molecular pathology molecular mechanisms mitigate radiation metabolic processes mainly involved lipid transport kyoto encyclopedia irradiated rats increased expression gene ontology findings suggest could serve clinical intervention cell adhesion biological processes associated pathways
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia

GO analysis of downregulated DEPs.
Tekijä: Jing Liu (38537)
Julkaistu: (2025)

GO analysis of upregulated DEPs.
Tekijä: Jing Liu (38537)
Julkaistu: (2025)

PPI network analysis of DEPs.
Tekijä: Jing Liu (38537)
Julkaistu: (2025)

KEGG enrichment analysis of DEPs.
Tekijä: Jing Liu (38537)
Julkaistu: (2025)

KEGG analysis of downregulated DEPs.
Tekijä: Jing Liu (38537)
Julkaistu: (2025)

KEGG analysis of upregulated DEPs.
Tekijä: Jing Liu (38537)
Julkaistu: (2025)

DEPs based on subcellular localization.
Tekijä: Jing Liu (38537)
Julkaistu: (2025)

DEPs based on structural domains.
Tekijä: Jing Liu (38537)
Julkaistu: (2025)

Classification of DEPs based on structural domains and subcellular localization.
Tekijä: Jing Liu (38537)
Julkaistu: (2025)

Volcano plot and heatmap of DEPs between RIBI and control tissues.
Tekijä: Jing Liu (38537)
Julkaistu: (2025)

Immunohistochemical staining for PHLDA3, APOE, and CPE in irradiated brain tissues.
Tekijä: Jing Liu (38537)
Julkaistu: (2025)

Principal component analysis and repeatability analysis.
Tekijä: Jing Liu (38537)
Julkaistu: (2025)

Representative HE staining images of brain tissues.
Tekijä: Jing Liu (38537)
Julkaistu: (2025)

Differentially expressed proteins.
Tekijä: Jing Liu (38537)
Julkaistu: (2025)

Fluvastatin inhibits the migration of melanoma A375 cells in a wound healing assay.
Tekijä: Jingxin Zeng (18773484)
Julkaistu: (2025)

Discovery of therapeutic compounds targeting brain metastasis-associated tumor cells (MBMATCs) in high MBM-Index melanoma.
Tekijä: Jingxin Zeng (18773484)
Julkaistu: (2025)

The MBM-Index as an independent predictor of overall survival (OS) in melanoma.
Tekijä: Jingxin Zeng (18773484)
Julkaistu: (2025)

Identification of melanoma brain metastasis-associated tumor cell subpopulations (MBMATCs).
Tekijä: Jingxin Zeng (18773484)
Julkaistu: (2025)

Tumor cell-specific transcriptomic features across PTs, ECMs and MBMs.
Tekijä: Jingxin Zeng (18773484)
Julkaistu: (2025)

Immune landscape and CD8<sup>+</sup> T cell transition states in PTs, ECMs and MBMs.
Tekijä: Jingxin Zeng (18773484)
Julkaistu: (2025)

Single cell RNA-seq and snRNA-seq profiling of the PTs (primary melanoma), ECMs (extracranial melanoma metastases) and MBMs (melanoma brain metastases) environments.
Tekijä: Jingxin Zeng (18773484)
Julkaistu: (2025)

Samples & cell type composition in melanoma tumor cells.
Tekijä: Jingxin Zeng (18773484)
Julkaistu: (2025)

Marker genes in melanoma tumor cells across PT, ECM and MBM by sc/snRNA-seq.
Tekijä: Jingxin Zeng (18773484)
Julkaistu: (2025)

AXL and MITF signature genes.
Tekijä: Jingxin Zeng (18773484)
Julkaistu: (2025)

Samples & cell type composition in sc/snRNA-seq.
Tekijä: Jingxin Zeng (18773484)
Julkaistu: (2025)

Identification of therapeutic drugs with high drug sensitivity for brain metastasis-associated tumor cells (MBMATCs) and high-brain metastasis (MBM) index patients.
Tekijä: Jingxin Zeng (18773484)
Julkaistu: (2025)

The enriched pathway by all transcripts differentially expressed between MBMATCs and other tumor cells, and between MBM-High and MBM-Low groups.
Tekijä: Jingxin Zeng (18773484)
Julkaistu: (2025)

The MBM-Index showed no significant correlation with clinicopathological features.
Tekijä: Jingxin Zeng (18773484)
Julkaistu: (2025)

Interaction between MBMATCs and the immune microenvironment.
Tekijä: Jingxin Zeng (18773484)
Julkaistu: (2025)

Pseudotime trajectory analysis of melanoma clusters Mela4 and Mela5.
Tekijä: Jingxin Zeng (18773484)
Julkaistu: (2025)

Immune cells profiling in PTs, ECMs and MBMs.
Tekijä: Jingxin Zeng (18773484)
Julkaistu: (2025)

scRNA-seq and snRNA-seq profiling of 26 melanoma samples.
Tekijä: Jingxin Zeng (18773484)
Julkaistu: (2025)

Supplementary Figure S1 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
Tekijä: Rumani Singh (17141575)
Julkaistu: (2025)

Supplementary Figure S2 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
Tekijä: Rumani Singh (17141575)
Julkaistu: (2025)

Supplementary Figure S3 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
Tekijä: Rumani Singh (17141575)
Julkaistu: (2025)

Supplementary Figure S4 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
Tekijä: Rumani Singh (17141575)
Julkaistu: (2025)

Supplementary Figure S5 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
Tekijä: Rumani Singh (17141575)
Julkaistu: (2025)

Supplementary Figure S6 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
Tekijä: Rumani Singh (17141575)
Julkaistu: (2025)

Table 1_Cerebrospinal fluid proteomic profiling reveals potential biomarkers and altered pathways in myotonic dystrophy type 1.docx
Tekijä: Marwa Zafarullah (12527002)
Julkaistu: (2025)

Statistical comparison (<i>p</i>-values) of Lempel-Ziv complexity (LZC) and Permutation Entropy (PE), for low frequency components of the signal across sleep states within each condition.
Tekijä: Magaly Catanzariti (20865500)
Julkaistu: (2025)

Cannot write session to /tmp/vufind_sessions/sess_j59p0mrm0quqh87cb8itmfe6og